Showing results (261-270 of 453) with videos related to
Sort By:
Pageof 46
Human Brain Mapping|December 19, 2015
Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PETHelen L Sigurdardottir, Georg S Kranz, Christina Rami-Mark, et al.American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 4, 2017
Investigation of SHANK3 in schizophreniaAna de Sena Cortabitarte, Franziska Degenhardt, Jana Strohmaier, et al.Frontiers in Public Health|January 9, 2014
A Positive Association between T. gondii Seropositivity and ObesityGloria M Reeves, Sara Mazaheri, Soren Snitker, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 16, 2012
Genetics of emergent suicidality during antidepressive treatment--data from a naturalistic study on a large sample of inpatients with a major depressive episodeRichard Musil, Peter Zill, Florian Seemüller, et al.Journal of Psychiatric Research|June 30, 2026
Cumulative depressive burden, functional impairment, depressive symptomatology and treatment response in Major Depressive Disorder: results from the STAR∗D and GSRD studiesMaria Luca, Paolo Olgiati, Antonina Luca, et al.Schizophrenia Bulletin|March 10, 2015
Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for interventionRichard J Drake, Merete Nordentoft, Gillian Haddock, et al.Cell|March 6, 2012
Interplay between DISC1 and GABA signaling regulates neurogenesis in mice and risk for schizophreniaJu Young Kim, Cindy Y Liu, Fengyu Zhang, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 17, 2009
Serotonin depletion hampers survival and proliferation in neurospheres derived from adult neural stem cellsJens Benninghoff, Angela Gritti, Matteo Rizzi, et al.Schizophrenia Bulletin|March 20, 2015
The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.Journal of Psychiatric Research|November 24, 2015
Combined Toxoplasma gondii seropositivity and high blood kynurenine--Linked with nonfatal suicidal self-directed violence in patients with schizophreniaOlaoluwa Okusaga, Erica Duncan, Patricia Langenberg, et al.Pageof 46